Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer Patients

Published:2019-01-15 Issue:1 Volume:51 Page:357-367
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Kim Hyery,Kang Hyoung Jin,Park Kyung Duk,Koh Kyung-Nam,Im Ho Joon,Seo Jong Jin,Lee Jae Wook,Chung Nack-Gyun,Cho Bin,Kim Hack Ki,Lee Jae Min,Hah Jeong Ok,Lee Jun Ah,Lee Young Ho,Park Sang Kyu,Baek Hee Jo,Kook Hoon,Kim Ji Yoon,Kim Heung Sik,Kim Hwang Min,Chueh Hee Won,Park Meerim,Yoon Hoi Soo,Lee Mee Jeong,Choi Hyoung Soo,Ahn Hyo Seop,Kawano Yoshifumi,Park Ji Won,Hahn Seokyung,Shin Hee Young

Funder

Ministry of Food and Drug Safety

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2017-457.pdf

Reference21 articles.

1. Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

2. Subsequent hospitalisation experience of 5-year survivors of childhood, adolescent, and young adult cancer in Scotland: a population based, retrospective cohort study

3. Dexrazoxane for Preventing Anthracycline Cardiotoxicity in Children with Solid Tumors

4. Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane

5. Dexrazoxane-Associated Risk for Acute Myeloid Leukemia/Myelodysplastic Syndrome and Other Secondary Malignancies in Pediatric Hodgkin's Disease

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Cardio-Oncology: Screening, Risk Stratification, and Prevention of Cardiotoxicity Associated with Anthracyclines;Children;2024-07-22

2. Circ-0006332 stimulates cardiomyocyte pyroptosis via the miR-143/TLR2 axis to promote doxorubicin-induced cardiac damage;Epigenetics;2024-07-17

3. Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage;Toxicological Sciences;2024-01-30

4. Myeloid Neoplasms Postcytotoxic Therapy in Children;Pediatric Oncology;2024

5. Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children;Pharmaceutics;2023-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3